세계의 심혈관 임플란트 시장

Global Cardiovascular Implants Market to Reach US$43.5 Billion by 2030

The global market for Cardiovascular Implants estimated at US$31.1 Billion in the year 2023, is expected to reach US$43.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Stents, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$18.7 Billion by the end of the analysis period. Growth in the ICD segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.5 Billion While China is Forecast to Grow at 4.5% CAGR

The Cardiovascular Implants market in the U.S. is estimated at US$8.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Cardiovascular Implants Market - Key Trends and Drivers Summarized

How Are Cardiovascular Implants Transforming the Treatment of Heart Conditions?

Cardiovascular implants are specialized medical devices designed to treat and manage a wide range of heart-related conditions by either supporting or replacing damaged cardiovascular structures. These devices include a variety of tools such as pacemakers, which help regulate abnormal heart rhythms (arrhythmias), stents that keep arteries open to maintain proper blood flow, and heart valves that replace diseased or malfunctioning valves within the heart. Other important types of cardiovascular implants include implantable cardioverter defibrillators (ICDs), which monitor and correct life-threatening irregular heartbeats, and ventricular assist devices (VADs), which help a weakened heart pump blood throughout the body. The critical importance of cardiovascular implants stems from their ability to address some of the most severe and life-threatening heart conditions. For example, pacemakers and ICDs are used in patients suffering from arrhythmias, where the heart beats too fast, too slow, or irregularly, and can help prevent sudden cardiac arrest. Stents are lifesaving in cases of coronary artery disease, where blocked arteries can lead to heart attacks. By keeping these arteries open, stents ensure continuous blood flow to the heart muscle, preventing severe complications. Similarly, heart valve implants, whether mechanical or biological, are used to replace valves that are either narrowed (stenosis) or leaky (regurgitation), helping the heart to maintain efficient blood circulation. As heart conditions like heart failure, coronary artery disease, and valve disorders become more prevalent, cardiovascular implants have emerged as one of the most effective and reliable treatment options for patients who would otherwise face severe limitations in quality of life, or even premature death. By restoring normal heart function or supporting a failing heart, these implants help patients return to their daily activities with a significant reduction in symptoms like shortness of breath, chest pain, or fatigue.

How Has Technology Enhanced Cardiovascular Implants?

Technological advancements have greatly enhanced the effectiveness, safety, and durability of cardiovascular implants, making them more reliable and accessible for a broader range of patients. One of the most significant innovations has been the development of miniaturized, less invasive devices. For example, modern pacemakers are much smaller than their predecessors and can now be implanted without the need for invasive surgery, significantly reducing recovery times and the risk of complications. Similarly, drug-eluting stents have been developed to not only physically support blood vessels but also release medication to prevent the re-narrowing of arteries over time. In the field of heart valve replacement, transcatheter valve implantation has emerged as a minimally invasive alternative to traditional open-heart surgery, allowing high-risk patients to receive life-saving implants without the risks associated with major surgery. Additionally, advancements in biocompatible materials have made implants more durable and better integrated with the human body, reducing the chances of rejection and improving long-term outcomes. Wearable technology and remote monitoring systems are now integrated with many implants, allowing healthcare providers to monitor a patient's heart function in real time and adjust treatment plans remotely if necessary. This has significantly improved patient care by enabling early intervention when problems arise. Furthermore, artificial intelligence and machine learning are being incorporated into these devices, offering the potential to predict and prevent complications by analyzing patient data and detecting irregularities before they lead to serious health events. These innovations are reshaping the landscape of cardiovascular care, making implants safer, more effective, and more patient-friendly than ever before.

What Trends Are Shaping the Cardiovascular Implants Market?

Several key trends are driving the growth and development of the cardiovascular implants market, reflecting advancements in medical technology, changing patient demographics, and evolving healthcare practices. One of the most important trends is the increasing demand for minimally invasive procedures. As more patients and healthcare providers seek less invasive options to avoid the complications and recovery time associated with traditional surgeries, cardiovascular implants that can be delivered via catheters or small incisions are becoming more popular. This trend is particularly evident in the rising use of transcatheter aortic valve replacement (TAVR) procedures, which allow patients with severe aortic stenosis to receive life-saving valve implants without open-heart surgery. Another major trend shaping the market is the growing prevalence of cardiovascular diseases, driven by aging populations and the rise in lifestyle-related conditions such as obesity, diabetes, and hypertension. As the number of patients with heart disease continues to rise, so does the need for cardiovascular implants to treat these conditions. This demand is also fueled by advancements in patient monitoring and data analytics, which enable more personalized and proactive care. Remote monitoring technologies that allow clinicians to track the performance of implants in real-time are becoming increasingly common, allowing for quicker adjustments and interventions if necessary. The trend towards integrating AI and machine learning into implantable devices is also having a profound impact. These technologies allow devices to adapt to changing patient conditions, predict potential problems, and optimize therapy in real-time, making them smarter and more efficient. Moreover, there is growing interest in developing biodegradable stents and other temporary cardiovascular implants that can perform their function and then naturally dissolve, reducing the need for further surgical interventions. As these trends continue to evolve, they are likely to further expand the capabilities and applications of cardiovascular implants in treating a wide range of heart conditions.

What Factors Are Driving the Growth of the Cardiovascular Implants Market?

The growth in the cardiovascular implants market is driven by several factors linked to technological advancements, demographic shifts, and evolving healthcare trends. One of the most prominent drivers is the rising incidence of cardiovascular diseases globally, particularly in aging populations and among individuals with risk factors such as diabetes, hypertension, and obesity. As more patients require long-term management of heart conditions, the demand for cardiovascular implants, such as pacemakers, stents, and artificial valves, continues to rise. Technological innovations have also been a key growth driver. The development of minimally invasive implant procedures, such as transcatheter valve replacements and leadless pacemakers, has broadened the patient pool eligible for these treatments, particularly among high-risk individuals who cannot undergo traditional surgery. Another significant driver is the integration of remote monitoring and AI into implantable devices. These advancements allow for real-time data tracking and predictive analytics, enabling healthcare providers to monitor a patient’s condition continuously and make timely adjustments to treatment plans. This proactive approach to managing heart conditions improves patient outcomes and reduces the need for emergency interventions or hospital readmissions. Additionally, the increased focus on patient-specific treatment plans and personalized medicine has led to the development of implants tailored to individual patient needs, further boosting market growth. Regulatory approvals and government initiatives aimed at improving access to advanced medical technologies have also contributed to the expansion of the cardiovascular implants market. In regions such as North America and Europe, streamlined regulatory processes have accelerated the introduction of new, cutting-edge implants into clinical practice. Furthermore, increasing healthcare expenditure in emerging markets has improved access to advanced cardiovascular care, driving the adoption of implants in these regions. Finally, the shift towards value-based healthcare, where the focus is on long-term patient outcomes rather than short-term treatments, has incentivized the use of durable and reliable cardiovascular implants, further propelling market growth.

Select Competitors (Total 29 Featured) -

• Abbott Laboratories
• AMG International
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Dimensions Pty. Ltd.
• Cardiac Science Corporation
• Edwards Lifesciences Corporation
• Japan Lifeline Co., Ltd.
• Medtronic PLC
• QualiMed Innovative Medizinprodukte GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Cardiovascular Implants - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Prevalence of Cardiovascular Diseases Spurs Demand for Cardiovascular Implants
  • Advancements in Biocompatible Materials Strengthen the Business Case for Next-Generation Implants
  • Aging Population and Increasing Incidence of Heart Failure Propel Growth of Cardiovascular Implants Market
  • Shift Toward Minimally Invasive Procedures Expands Addressable Market for Advanced Cardiovascular Implants
  • Here's How Wearable Technology and Remote Monitoring Capabilities Drive Adoption of Smart Cardiovascular Implants
  • Growing Adoption of Transcatheter Implant Procedures Spurs Demand for Innovative Cardiovascular Solutions
  • Post-Surgical Monitoring Capabilities Boost Demand for Intelligent Cardiovascular Implants
  • Growing Use of 3D Printing Technology in Cardiovascular Implants Propels Innovation and Market Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cardiovascular Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for ICD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Heart Valve by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Implanted Cardiac Pacemaker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for CRT Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: Canada 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• JAPAN
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Japan Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Japan 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• CHINA
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 29: China Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: China Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: China 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• EUROPE
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 33: Europe Historic Review for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Europe 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• FRANCE
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: France Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: France 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• GERMANY
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Germany Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Germany 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Italy Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Italy 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: UK Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: UK 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Asia-Pacific 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Rest of World Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Rest of World 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030

IV. COMPETITION